Clinical Trials
Riverside is here for you during the COVID-19 outbreak.

For more information, please click here.

HEART-FID - A Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure With Iron Deficiency

The primary objective of this study is to determine the efficacy and safety of iron therapy using intravenous (IV) ferric carboxymaltose (FCM), relative to placebo, in the treatment of participants in heart failure with iron deficiency and with a reduced ejection fraction.

Principal Investigator

Edward Chu, MD

Contact

Virginia Barch, RN, MSN, CCRC

757-594-4508
[email protected]

Locations

Riverside Regional Medical Center
500 J. Clyde Morris Blvd.
Newport News, VA 23601

Status

Recruiting

Category

Cardiology

Study #

NCT03037931